Search
for
Sort by
Research 151–180 of 1000+
- VEPA and ML-Y1 Regimen for Elderly Non-Hodgkin's Lymphoma.
- Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Topical Gene Electrotransfer to the Epidermis of Hairless Guinea Pig by Non-Invasive Multielectrode Array
- Morphological characteristics and notes of the skin in preclinical toxicity assessment
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Concomitant acute alopecia and profound bone marrow suppression: An unusual manifestation of azathioprine toxicity
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Abemaciclib-Associated Skin, Hair, and Nail Toxicities: A Case Report
- Skin toxicity caused by EGFR antagonists—An autoinflammatory condition triggered by deregulated IL‐1 signaling?
- Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study
- Effects of non-ablative fractional erbium glass laser treatment on gene regulation in human three-dimensional skin models
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Dermatological adverse events with taxane chemotherapy
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Cystoid macular oedema in uveitis: An unsolved problem
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Toxicity of repeated oral intake of organic selenium, inorganic selenium, and selenium nanoparticles: A review
- Alopecia - the search for novel agents continues
- Basic concepts, current evidence, and future potential for gene therapy in managing cutaneous wounds
- Contents
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- The pharmacology of methotrexate
- Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages
- Comparison of finasteride versus flutamide in the treatment of hirsutism
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Oral Retinoids in Dermatology